Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

Paragraphs

COVID-19 presents humanity with not just a health crisis but also a governance crisis as leaders around the globe confront the challenges of stemming the spread of the virus. Various governments have responded in various ways to slow the transmission of the virus. Ideally, the leaders of a country should approach the crisis with a two-pronged attack. The first is to flatten the epidemic curve (epi curve), which is simply a graphical representation of the number of cases and date of onset of the illness, and the second is to raise or strengthen the capacity of the health system. 

Flattening the epi curve includes mass testing for COVID-19, which has been done in South Korea, for example. Decreasing the incidence also includes quarantine, isolation, and other social distancing strategies, which have been done by various countries in varying degrees. For example, in China, total lockdown (cordon sanitaire) was implemented in Wuhan, of the Hubei province, while in the Philippines, the entire Luzon, which consists of eight administrative regions, including the national capital region (NCR), was in total lockdown (enhanced community quarantine, or ECQ) since March 16 (World Health Organization [WHO] 2020a). Other parts of the Philippines were under different degrees of quarantine at different periods since the appearance of local transmission.

Raising the health care system capacity of a country may include, but is not limited to, training of health care workers, increasing facilities or hospitals that receive COVID patients, and providing adequate personal protective equipment (PPE).

This paper offers a brief epidemiological review of COVID-19 since its first case in China and how the hotspots for this disease evolved and changed over a relatively short period. This paper also aims to provide a short descriptive review of the existing data on COVID-19 in the Association of Southeast Asian Nations (ASEAN) region and the government response of its ten member countries, so that we can somehow draw lessons and learn from these myriad experiences as we continue to combat the spread of this dangerous pathogen. The findings in this paper are preliminary, and more rigorous analysis is expected to be performed as the data becomes more extensive and available.

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Asia Health Policy Program working paper # 58
Authors
Marjorie Pajaron
News Type
Q&As
Date
Paragraphs

This interview was originally produced by the Oliver Wyman Forum.

Coronavirus has dramatically increased the use of technology as governments, healthcare providers, and businesses tackle the pandemic and its devastation. But even before the crisis, Japan, a country long at the forefront of robot production and usage, had begun to use this technology in many of its nursing homes.

About 60 percent of the country’s nursing facilities now use robots. The proliferation of machines has had a relatively minor impact on turnover or wages of caregivers because of strong demand for care, an aging working population, and government subsidies for robot implementation, according to research by Karen Eggleston, the deputy director of the Shorenstein Asia-Pacific Research Center and director of the Asia Health Policy Program (AHPP), Yong Suk Lee, a center fellow and the deputy director of the Korea Program, and Toshi Iizuka, professor at the University of Tokyo and former visiting scholar with AHPP. Robot-adopting nursing homes, the researchers found, had between eight to 11 percent more staff than those who didn't adopt robots.

Caregiving is a physically demanding task. Staff frequently lift residents in and out of bed, and many suffer from back pain. Many of the robots deployed in Japan either help caregivers perform physical tasks or facilitate movement by the residents themselves.

The research couldn’t be timelier. Nursing homes have taken a heavy toll from the coronavirus. The disease has claimed the lives of more than 28,000 residents and workers of care facilities in the United States – approximately 35 percent of all deaths in the nation as of May 11. By contrast, Japan’s overall death toll stands at a little over 900 in early June.

Professors Eggleston and Lee discussed the implications of their research in a Zoom interview with Partha Bose, a partner at Oliver Wyman and a leader of the Oliver Wyman Forum, as well as Jilian Mincer, managing editor of the Oliver Wyman Forum, and Dan Kleinman, the Forum’s digital editor.

[Like what you're reading? Sign up for our newsletters to get content like this delivered directly to your inbox.]

From a labor economics point of view, Japan has been struggling with staffing in these care facilities. What made it much more acceptable for robots to be used in their situation versus other sectors?

Karen Eggleston: Japan has an extreme demography that it’s dealing with. The demand for long-term care is going up quite a bit while the overall population is declining. Although they're relaxing some immigration, there are issues with that. Some of the policy goals were to support robotics and to understand how it complements or substitutes for specific tasks in long-term care — to bring down back pain among care workers, for example — and to explicitly set a target for percentage of healthcare providers and long-term care clients who say it's acceptable to have a robot involved in their care.

They went into it well aware that robots weren't going to completely push out the workforce, but it's all a question of what type of tasks they can be involved with and how they can get an early read on that and start developing appropriate robots and re-engineering the care processes to meet that surge in demand.

What kinds of tasks are robots being used for in Japan right now?

Yong Suk Lee: There are these wearable transfer-aid robots that can actually help care workers lift persons and move around. There are similar types of robots that are non-wearable. And there are robots that directly assist the elderly in their care: They can use these to move around, and related to that, bathing activities, going to the bathroom, and so on.

The main type of robots are monitoring robots. They’re basically a camera system. They signal to the nurses or caregivers in an aid station if there seems to be abnormal movement so that they can actually go there — especially during the night when there's less staffing to actually go and check how the residents are doing. Those are the highest in terms of rate of adoption. And then there are those cute communication types of robots to help patients with dementia communicate with their families and caregivers.
 
What sort of facilities are using these robots? Do they tend to be urban facilities, or can they be anywhere in the country, like rural areas?

Lee: Based on preliminary results, adoption is higher in urban areas, but it's not significantly different. In China, it could differ drastically because there's a huge urban-rural divide in China of public health systems or public service in general. Robots are capital intensive. In South Korea, there are private homes that are wealthier and those could adopt new technologies earlier, but still, adoption in general is not widespread due to sufficient immigrant labor providing care. There could be an urban-rural divide for sure. Because of government subsidies in Japan, it equalizes distribution across regions.
 
Eggleston: We find more part-time or irregular nurses in urban areas. That may seem counterintuitive, but when you think about it, having that concentration of human capital in urban areas might facilitate that kind of part-time work and so on. There are differences we can see in our data between urban and rural homes, but we don't see large differences in terms of robot adoption and use.

Are there kinds of conditions that robots are better suited for than others?

Lee: In general, most robots are related to mobility issues. The biggest consequences of the elderly staying in homes are pressure ulcers on their skin because of their extended time in bed and low levels of mobility. Robots could provide a major contribution if they help residents move about and reduce pressure ulcers.

Communication robots are helpful for patients with dementia. The adoption of those isn't high compared to monitoring robots, but I think it's becoming more accepted and especially helpful for certain types of patients.
 
Do you think robots will be helpful for medical care?

Eggleston: That's the hope. For example, night monitoring reduces the probability of a severe fall which requires hospitalization and so on. There are contentious issues with nursing homes about physical restraints for patients, which are not allowed. And so, adding robots might deal with some of the outcomes. Both the producers and users of robots are hoping this will have a significant impact on the quality of care. 

As you look at how the coronavirus has affected long-term care facilities, do you wonder what the outcomes might've been had some of these facilities had robots?

Lee: Yes. What our findings indicate is that robots are not replacing workers in Japan. They're allowing firms to adopt more nurses — the skilled type of caregivers, which is an important finding directly related to the quality of care. Allowing critical personnel to actually focus more on patients. If there were certain technologies in place, caregivers could have spent their time more efficiently. I believe that's going to be a discussion going forward in the US and in many other countries that have suffered drastically. 

Eggleston: Particularly the communication and monitoring robots would help to some extent. They can save caregivers from having to go room-to-room and enable communication between people at the facility, and also with their households.

We do know that there's a potential there, and it might affect future adoption in nursing homes in the US and elsewhere. But given the huge financial hit the industry has taken as a whole, it might be a while before that plays out.

Given the coronavirus’s prevalence in nursing homes, people may be wary of taking jobs there. Can these robots be used in a recruiting capacity for nursing homes?

Lee: Certified nursing assistants in the US are not well-paid and it’s a physically demanding job. Now there's an extra concern of, "What will happen to me when I work here?" A lot of nursing homes had enormous difficulty recruiting people. They were paying extra for nurse aids, but they weren't able to recruit given the situation.

Potentially, nursing home facilities that have the capacity to adopt robots may be able to advertise this as not only being able to improve the quality of care for the residents but providing better work conditions for the caregivers. What we're finding in our research is those that adopt these robots tend to have better management practices.

What has surprised you most in your research?

Lee: We didn't find that robots replaced care workers. They’re being used to supplement the workers and maybe have better outcomes in quality of care. This is having an overall net positive effect both on jobs and productivity.

Read More

Cover image of the book "Healthy Aging in Asia", showing a smiling elderly Chinese woman with a cane standing in a small village.
News

New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia

Asia health policy expert Karen Eggleston’s new volume, ‘Healthy Aging in Asia,’ examines how diverse Asian economies – from Singapore and Hong Kong to Japan, India, and China – are preparing for older population age structures and transforming health systems to support patients who will live with chronic disease for decades.
New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia
Michael McFaul, Xueguang Zhou, Karen Eggleston, Gi-Wook Shin, Don Emmerson, and Yong Suk Lee
News

FSI Hosts APARC Panel on COVID-19 Impacts in Asia

Scholars from each of APARC's programs offer insights on policy responses to COVID-19 throughout Asia.
FSI Hosts APARC Panel on COVID-19 Impacts in Asia
Hero Image
A robot names Pepper
Courtesy of Alex Knight, Unsplash
All News button
1
Subtitle

Karen Eggleston and Yong Suk Lee speak to the Oliver Wyman Forum on how robotics and advancing technologies are helping staff in Japanese nursing homes provide better and safer care to their patients.

News Type
News
Date
Paragraphs

On May 15, 2020, the King Center on Global Development held a virtual panel discussion with the Shorenstein APARC on the economic impact of COVID-19 in China. As China lifts its lockdown and U.S. cases of COVID-19 ramp up, three APARC faculty members — Karen Eggleston, Scott Rozelle, and Xueguang Zhou — joined the King Center’s China Program Director Hongbin Li to analyze the Chinese government’s initial response to the coronavirus outbreak and how the virus has impacted urban and rural employment in China’s health care sectors. Watch the panel discussion:

Read More

Michael McFaul, Xueguang Zhou, Karen Eggleston, Gi-Wook Shin, Don Emmerson, and Yong Suk Lee
News

FSI Hosts APARC Panel on COVID-19 Impacts in Asia

Scholars from each of APARC's programs offer insights on policy responses to COVID-19 throughout Asia.
FSI Hosts APARC Panel on COVID-19 Impacts in Asia
Hero Image
Karen Eggleston, Hongbin Li, Scott Rozelle, and Xueguang Zhou during a virtual panel discussion
All News button
1
Subtitle

Karen Eggleston, Scott Rozelle, and Xueguang Zhou join the King Center on Global Development’s Hongbin Li to examine how COVID-19 has impacted urban and rural employment in China’s health care sectors.

Date Label
-

This event is via Zoom Webinar. Please register in advance for the webinar by using the link below.

REGISTRATION LINKhttps://bit.ly/2xZHser

Part of APARC series COVID-19 IN ASIA: RESPONSES AND IMPLICATIONS FOR THE REGION

Co-sponsored by the Asia Health Policy Program and the Southeast Asia Program

Speakers (live and pre-recorded):

Dr. Dorairaj Prabhakaran, Professor of chronic disease epidemiology, Public Health Foundation of India, and Executive Director, Center for Chronic Disease Control.

Dr. Pham Quang Thai, Member of the Vietnam Steering Committee for COVID-19 Prevention and Control

Dr. HAC Van Vinh, Associate Professor & former Dean of Research & International Relations, Thai Nguyen University of Medicine and Pharmacy

Dr. Richard Cash, Senior Lecturer on Global Health, T.H. Chan School of Public Health, Harvard University

Dr. Radhika Jain, Asia Health Policy Postdoctoral Fellow, APARC, FSI, Stanford University

Dr. Arzan Tarapore, Research Scholar, APARC, FSI, Stanford University

How is the pandemic impacting health systems and society in south and southeast Asia? Numerous experts share their perspectives on topics ranging from COVID-19 challenges in Bangladesh, India and Vietnam, to geopolitical considerations for U.S. policy in the wider Indo-Pacific.

Via Zoom Webinar.

Register at https://bit.ly/2xZHser

Dorairaj Prabhakaran Professor of chronic disease epidemiology, Public Health Foundation of India, and Executive Director, Center for Chronic Disease Control.
Pham Quang Thai Member of the Vietnam Steering Committee for COVID-19 Prevention and Control
HAC Van Vinh Associate Professor & former Dean of Research & International Relations, Thai Nguyen University of Medicine and Pharmacy
Richard Cash Senior Lecturer on Global Health, T.H. Chan School of Public Health, Harvard University
Shorenstein APARC Stanford University Encina Hall E301 Stanford, CA 94305-6055
1
Asia Health Policy Postdoctoral Fellow, 2019-2022
radhika_jain.jpg Ph.D.

Radhika Jain was the Asia Health Policy Postdoctoral Fellow for 2019-2022 at the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC).  Her research focuses on health care markets, the effectiveness of public health policy, and gender disparities in health.

She completed her doctorate in the Department of Global Health at Harvard University in 2019.  Her dissertation examined the extent to which government subsidies for health care under insurance are captured by private hospitals instead of being passed through to patients, and whether accountability measures can help patients claim their entitlements. Dr. Jain's research has been supported by grants from the Weiss Family Fund and the Jameel Poverty Action Lab (JPAL). She has worked on impact evaluations of health programs in India and on the implementation of HIV programs across several countries in sub-Saharan Africa. She also held a doctoral fellowship at the Center for Global Development.

At Shorenstein APARC, Radhika began new work on understanding the factors that contribute to poor female health outcomes and interventions to increase the effectiveness of public health insurance.

Asia Health Policy Postdoctoral Fellow, APARC, FSI, Stanford University
Arzan Tarapore Research Scholar, APARC, FSI, Stanford University
Panel Discussions
Paragraphs

The intention to pay for human papillomavirus (HPV) vaccination among women of childbearing age in Vietnam, where cervical cancer remains a significant public health concern, has been mostly lacking. To examine this issue, we conducted a cross-sectional study of 807 pregnant women in an urban and a rural district (Dong Da and Ba Vi) of Hanoi, Vietnam. The vast percentage of our respondents expressed a firm intention to vaccinate, especially women in rural areas (over 90.0%). However, on being informed of the current price of the HPV vaccine, their intention to vaccinate dropped to about one-fifth of overall respondents, i.e., only 4.4% of women in rural areas. It was also observed that the initial intention to get the HPV vaccination among women in the rural district was
about ten times higher than that of women living in the metropolitan district. Those participants who had greater knowledge of cervical cancer andHPV vaccinations also had a significantly higher intention to vaccinate. Our findings underscore the need to develop a well-designed vaccination program in Vietnam and other countries in a similar situation to increase the adoption of HPV vaccination.

Keywords: HPV vaccination; cervical cancer; intention; women; Vietnam

Published: Intention to Pay for HPV Vaccination among Women of Childbearing Age in Vietnam

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Asia Health Policy Program working paper # 57
Authors
Paragraphs
Cover of Healthy Aging in Asia that shows an elderly woman in a Chinese village.
Life expectancy in Japan, South Korea, and much of urban China has now outpaced that of the United States and other high-income countries. With this triumph of longevity, however, comes a rise in the burden of noncommunicable diseases (NCDs) like diabetes and hypertension, reducing healthy life years for individuals in these aging populations, as well as challenging the healthcare systems they rely on for appropriate care.  
 
The challenges and disparities are even more pressing in low- and middle-income economies, such as rural China and India. Moreover, the COVID-19 pandemic has underscored the vulnerability to newly emerging pathogens of older adults suffering from NCDs, and the importance of building long-term, resilient health systems. 
 
What strategies have been tried to prevent NCDs—the primary cause of morbidity and mortality — as well as to screen for early detection, raise the quality of care, improve medication adherence, reduce unnecessary hospitalizations and increase “value for money” in health spending? 
 
Fourteen concise chapters cover multiple aspects of policy initiatives for healthy aging and economic research on chronic disease control in diverse health systems — from cities such as Singapore and Hong Kong to large economies such as Japan, India, and China. 
 

Desk, examination, or review copies can be requested through Stanford University Press.

All Publications button
1
Publication Type
Books
Publication Date
Authors
Karen Eggleston
Book Publisher
Shorenstein APARC
-

This event is via Zoom Webinar. Please register in advance for the webinar by using the link below.

REGISTRATION LINKhttps://bit.ly/2Kpjiww

A Discussion between Matthew Kohrman and Gan Quan, co-editors of Poisonous Pandas: Chinese Cigarette Manufacturing in Critical Historical Perspectives (Stanford University Press, 2018).

Image
gan quan

 

 

 

Gan Quan (PhD, Berkeley) is the director of Tobacco Control of the International Union Against Tuberculosis and Lung Disease. His research tackles various topics pertaining to tobacco control in China.

 

 

 

 

 

Image
mathew kohrman

 

 

 

Matthew Kohrman (PhD, Harvard) is an associate professor in Stanford’s Department of Anthropology and senior fellow by courtesy at APARC/FSI. His research brings anthropological methods to bear on the ways health, culture, and politics are interrelated.

 

 

 

 

 

 

 

 

Via Zoom Webinar.

Register at https://bit.ly/2Kpjiww

Gan Quan Director of Tobacco Control of the International Union Against Tuberculosis and Lung Disease
Matthew Kohrman Associate Professor of Anthropology, Stanford University
Panel Discussions
News Type
News
Date
Paragraphs

To support Stanford students working in the area of contemporary Asia, the Shorenstein Asia-Pacific Research Center is offering up to ten research assistant internships for summer 2020 and up to three predoctoral fellowships for the 2020-21 academic year. The Center will review applications starting April 15 and expects to fill the positions by April 30, 2020. 

Amid the fallout of the COVID-19 pandemic, students are facing summer internship cancelations and hiring freezes. They are left wondering about the long-term implications of the current crisis for their academic careers and their access to future jobs and valuable work experience.

At Shorenstein APARC, we want to do all we can to support Stanford students. That’s why we are announcing new internship and fellowship opportunities for current students working in the area of contemporary Asia: research assistant internships for the summer quarter of 2020 and predoctoral fellowships for the 2020-21 academic year.

The summer internships are all remote: research assistants will work as telecommuters. Regarding the predoctoral fellowships, we hope we can all have a normal 2020-21 academic year, in which case we expect the fellows to be in residence, but we will reassess the evolving COVID-19 situation closer to the appointment start dates and shift to flexible, online options as needed.

APARC will review applications for both opportunities on a rolling basis starting April 15, 2020. The Center will select up to ten research assistants and up to three predoctoral fellows by April 30, 2020.

Read on to learn more about these offerings and the application requirements, and follow the guidelines below to submit your candidacy.

Summer 2020 APARC Research Assistant Internships

Shorenstein APARC is seeking highly motivated and dedicated undergraduate and graduate students to join our team as paid research assistant interns for the summer quarter of 2020. Research assistants will work with assigned APARC faculty members on projects focused on contemporary Asia, studying varied issues related to the politics, economies, populations, security, foreign policies, and international relations of the countries of the Asia-Pacific region.

All positions will be for eight weeks starting late June or early July 2020. The hourly pay rate is $17 for undergraduate students, $25 for graduate students.

Research assistant positions are open to current Stanford students only. Undergraduate- and graduate-level students are eligible to apply.

Apply Now

  • Complete the application form and submit it along with these two (2) required attachments:
    • CV;
    • A cover letter (up to 1 page).
  • Arrange for a letter of recommendation from a faculty to be sent directly to APARC. Please note: the faculty members should email their letters directly to Kristen Lee at kllee@stanford.edu.

We will consider only complete applications that include all the abovementioned supporting documents.  

2020-21 Shorenstein APARC Predoctoral Fellowships

APARC is inviting applications from current Stanford students for the 2020-21 Shorenstein APARC Predoctoral Fellowship. The fellowship supports predoctoral students working within a broad range of topics related to contemporary Asia. 

Up to three fellowships are available to Ph.D. candidates who have completed all fieldwork and are nearing the completion of their dissertation. The Center will give priority to candidates who are prepared to finish their degree by the end of the 2020-21 academic year.

Shorenstein APARC offers a stipend of $36,075 for the 2020-21 academic year, plus Stanford's Terminal Graduate Registration (TGR) fee for three quarters. We expect fellows to remain in residence at the Center throughout the year and to participate in Center activities.

Apply Now

  • Complete the application form and submit it along with these three (3) required attachments:
    • CV;
    • A cover letter including a brief description of your dissertation (up to 5 double-spaced pages);
    • A copy of your transcripts. Transcripts should cover all graduate work and include evidence of recently-completed work.
  • Arrange for two (2) letters of recommendation from members of your dissertation committee to be sent directly to Shorenstein APARC. Please note: the faculty/advisors should email their letters directly to Kristen Lee at kllee@stanford.edu.

We will consider only complete applications that include all the abovementioned supporting documents. 

Hero Image
Architectural detail on Stanford colonnade with palm trees in the background
L.A. Cicero
All News button
1
-

This event is via Zoom Webinar. Please register in advance for the webinar by using the link below.

REGISTRATION LINKhttps://bit.ly/2VUQmTJ

The prevalence of obesity for adults aged 19 and over in Korea has risen from 25.8% in 1998 to 35.5% 2016, while it is still low compared with other developed countries. Body mass index (BMI), focusing on weight for a given height, has traditionally been used to define obesity despite of its shortcomings of not distinguishing between muscle and fat, being inaccurate in predicting the percentage of body fat (PBF), and being not a good measure for the risk of heart attack, stroke, or death. Another measure of abdominal obesity, the z-score of the log-transformed A Body Shape Index (LBSIZ), has been recently introduced to focus on waist circumference for a given both weight and height. We examine their respective association with the risk of diabetes using a cohort data from the Korean Genome and Epidemiology Study.

Image
picturewankyo cropped 4x4
Wankyo Chung is a Professor in the Department of Public Health Science, Graduate School of Public Health at Seoul National University, Seoul Korea. His research interests include economic evaluation of health care programs, equity in health, health policy, and prevention. He has been active as a board member of the Korea Expert Committee on Immunization Practices at Korea CDC, the Information Disclosing Council at Korea HIRA, and an editorial board member of the Korean Journal of Health Economics and Policy and the KDI Journal of Economic Policy. His work has been published regularly in leading international journals. He is currently studying risk prediction models for diabetes at the CEAS, Stanford.

Last few years, China have implemented several national initiatives, for example, the National Healthcare Improvement Initiative (NHII) launched in 2015, to improve patient experiences in healthcare, harmonize the relationship between patients and healthcare workers (i.e., doctors and nurses), and decrease medical disputes in public hospitals. However, reports of medical disputes and violence (verbal abuse or physical violence) against healthcare workers in tertiary public hospitals are still making headlines in China. To help understand and tackle these problems, based on a three-year longitudinal study (2017-2019) conducted in six leading tertiary public hospitals in Shaanxi, a west province of China, we try to depict these problems’ changes, identify the healthcare workers who are at a high risk of medical dispute and violence from patients or their families, and explore the potential causes. These findings could help governments and hospitals protect healthcare workers with more pertinence and build a better medical environment in China.

Image
jinlin liu hr 4x4
Jinlin Liu joins the Walter H. Shorenstein Asia-Pacific Research Center as visiting scholar during the 2019-2020 academic year from Xi'an Jiaotong University, where he serves as a researcher for the Research Center for the Belt and Road Health Policy and Health Technology Assessment. His research lies in the areas of health system and health policy in China, with emphasis on the public hospital governance and development of human resources for health. He obtains a Ph.D. in Public Administration from Xi'an Jiaotong University in 2018.

Via Zoom Webinar.

Register at https://bit.ly/2VUQmTJ

 

Wankyo Chung Professor in the Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul Korea
2019-2020 Walter H. Shorenstein Asia-Pacific Research Center Visiting Scholar
Panel Discussions
-

More than 80% of cardiovascular diseases (CVD) and diabetes mellitus (DM) burden now lies in low and middle-income countries. Thus, there is an urgent need to identify and implement the most cost-effective interventions, particularly in the resource-constraint South Asian settings. A 2018 systematic review evaluated the cost-effectiveness of individual-level, group-level and population-level interventions to control CVD and DM in South Asia. Of the 2949 identified studies through a search of 14 electronic databases up to 2016, 42 met full inclusion criteria. Critical appraisal of studies revealed 15 excellent, 18 good and 9 poor quality studies. Most studies were from India (n=37), followed by Bangladesh (n=3), Pakistan (n=2) and Bhutan (n=1). The economic evaluations were based on observational studies (n=9), randomised trials (n=12) and decision models (n=21). Together, these studies evaluated 301 policy or clinical interventions or combination of both. We found a large number of interventions were cost-effective aimed at primordial prevention (tobacco taxation, salt reduction legislation, food labelling and food advertising regulation), and primary and secondary prevention (multidrug therapy for CVD in high-risk group, lifestyle modification and metformin treatment for diabetes prevention, and screening for diabetes complications every 2–5 years). Significant heterogeneity in analytical framework and outcome measures used in these studies restricted meta-analysis and direct ranking of the interventions by their degree of cost-effectiveness. The cost-effectiveness evidence for CVD and DM interventions in South Asia is growing, but most evidence is from India and limited to decision modelled outcomes. There is an urgent need for formal health technology assessment and policy evaluations in South Asia and other low- and middle- income countries using local research data.

Image
kavita
I am Dr. Kavita Singh, interested in global cardiometabolic disease epidemiology and economic evaluations of interventions for prevention and control of chronic diseases in low- and middle- income countries. I am an Epidemiologist by training, and work as a research scientist at the Public Health Foundation of India. My research work has primarily focused on evaluating the long-term effectiveness and cost-effectiveness of a multicomponent quality improvement intervention (consisting of decision-support electronic health records to enhance physician’s responsiveness and care coordinators to improve patient’s adherence to therapy) in 1,146 patients with type 2 diabetes attending 10 tertiary care clinics in India and Pakistan as part of the National Heart Lung Blood Institute funded CARRS Trial. Recently, I have been awarded the Emerging Global Leader Award (K43 grant, 2019-2024), funded by the National Institutes of Health, Fogarty International Centre to conduct a research project that aims to develop and test the feasibility of a multicomponent cardiovascular quality improvement strategy for patients with established cardiovascular diseases (CVD) in India.

Kavita Singh 2019-2020 Walter H. Shorenstein Asia-Pacific Research Center Visiting Scholar
Seminars
Subscribe to Health and Medicine